|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.00 USD | +3.20% |
|
+2.76% | +7.71% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -8.31x | 3.87x | 3.62x | -6.69x | -6.28x | 2.07B | ||
| 0.62% | 0.7% | 16.36x | 1.9x | 3.55x | 9.58x | 10.48x | 64.28B | ||
| 0.56% | 0.57% | 28.32x | 4.27x | 5.77x | 16.88x | 21.02x | 57.29B | ||
| -.--% | -.--% | 35.89x | 7.21x | 12.16x | 23.03x | 27.05x | 43.45B | ||
| 3.59% | 3.68% | -56.58x | 2.33x | 3.05x | 9x | 10.5x | 38.02B | ||
| -.--% | -.--% | 34.98x | 1.72x | 3.72x | 11.41x | 13.28x | 31.98B | ||
| -.--% | -.--% | -8.06x | 4.75x | 11.55x | -7.04x | -6.67x | 27.66B | ||
| -.--% | -.--% | 16.64x | 3.33x | 3.17x | 9.59x | 9.5x | 22.91B | ||
| -.--% | 0.06% | 50.41x | 5.1x | 5.55x | 38.45x | 35.52x | 17.74B | ||
| -.--% | -.--% | 25.58x | 3.64x | 5.32x | 14.26x | 19.77x | 16.45B | ||
| -.--% | -.--% | -33.1x | -5.74x | 15.4x | -46.83x | -48.67x | 14.1B | ||
| 0.14% | 0.14% | 68.24x | 27.83x | 41.56x | 58.77x | 60.62x | 12.95B | ||
| -.--% | -.--% | -122.33x | 12771.19x | 12.48x | -110.56x | -121.48x | 12.41B | ||
| -.--% | -.--% | 49.05x | - | - | - | - | 11.15B | ||
| -.--% | -.--% | 16.37x | - | 3.5x | 12.84x | 15.39x | 11.15B | ||
| 2.84% | 3.28% | 11.84x | 1.03x | 1.81x | 7.31x | 9.79x | 6.27B | ||
| 1.64% | 1.82% | 13.68x | 1.26x | 2.38x | 6.24x | 7.46x | 5.51B | ||
| -.--% | -.--% | -103.64x | - | - | - | - | 5.07B | ||
| Average | 0.52% | 0.57% | 1.96x | 855.58x | 8.41x | 2.89x | 3.58x | 22.25B | |
| Weighted average by Cap. | 0.59% | 0.63% | 9.76x | 428.72x | 7.50x | 8.25x | 9.68x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















